Aquaculture

‘A pivotal point in its evolution’: Benchmark's radical restructuring is paying off

The fish health and genetics group is still carrying 'luggage' from its 2020 restructuring, but it sees black numbers in its near future.

Trond Williksen, CEO of Benchmark, expects the bottom line to be cash positive by 2023 but is mindful it takes time to build up the business.
Trond Williksen, CEO of Benchmark, expects the bottom line to be cash positive by 2023 but is mindful it takes time to build up the business.Photo: Glenn Rokeberg
BenchmarkTrond WilliksenEarningsGeneticsSea lice
Published 23 February 2022, 06:32Updated 23 February 2022, 14:41